149 related articles for article (PubMed ID: 18831690)
1. CD4+ T helper cell responses against human bocavirus viral protein 2 viruslike particles in healthy adults.
Lindner J; Zehentmeier S; Franssila R; Barabas S; Schroeder J; Deml L; Modrow S
J Infect Dis; 2008 Dec; 198(11):1677-84. PubMed ID: 18831690
[TBL] [Abstract][Full Text] [Related]
2. Humoral immune response against human bocavirus VP2 virus-like particles.
Lindner J; Karalar L; Zehentmeier S; Plentz A; Pfister H; Struff W; Kertai M; Segerer H; Modrow S
Viral Immunol; 2008 Dec; 21(4):443-9. PubMed ID: 19115933
[TBL] [Abstract][Full Text] [Related]
3. Comparison of Th-cell immunity against human bocavirus and parvovirus B19: proliferation and cytokine responses are similar in magnitude but more closely interrelated with human bocavirus.
Kumar A; Filippone C; Lahtinen A; Hedman L; Söderlund-Venermo M; Hedman K; Franssila R
Scand J Immunol; 2011 Feb; 73(2):135-40. PubMed ID: 21198754
[TBL] [Abstract][Full Text] [Related]
4. ELISAs using human bocavirus VP2 virus-like particles for detection of antibodies against HBoV.
Lin F; Guan W; Cheng F; Yang N; Pintel D; Qiu J
J Virol Methods; 2008 Apr; 149(1):110-7. PubMed ID: 18289709
[TBL] [Abstract][Full Text] [Related]
5. Evidence of prior exposure to human bocavirus as determined by a retrospective serological study of 404 serum samples from adults in the United States.
Cecchini S; Negrete A; Virag T; Graham BS; Cohen JI; Kotin RM
Clin Vaccine Immunol; 2009 May; 16(5):597-604. PubMed ID: 19244471
[TBL] [Abstract][Full Text] [Related]
6. Seroepidemiology of human bocavirus defined using recombinant virus-like particles.
Kahn JS; Kesebir D; Cotmore SF; D'Abramo A; Cosby C; Weibel C; Tattersall P
J Infect Dis; 2008 Jul; 198(1):41-50. PubMed ID: 18491974
[TBL] [Abstract][Full Text] [Related]
7. Immunogenicity of recombinant human bocavirus-1,2 VP2 gene virus-like particles in mice.
Deng ZH; Hao YX; Yao LH; Xie ZP; Gao HC; Xie LY; Zhong LL; Zhang B; Cao YD; Duan ZJ
Immunology; 2014 May; 142(1):58-66. PubMed ID: 24843872
[TBL] [Abstract][Full Text] [Related]
8. Serodiagnosis of human bocavirus infection.
Kantola K; Hedman L; Allander T; Jartti T; Lehtinen P; Ruuskanen O; Hedman K; Söderlund-Venermo M
Clin Infect Dis; 2008 Feb; 46(4):540-6. PubMed ID: 18199037
[TBL] [Abstract][Full Text] [Related]
9. [Seroprevalence of antibody against human bocavirus in Beijing, China].
Zhao LQ; Qian Y; Zhu RN; Deng J; Wang F; Dong HJ; Li Y
Zhonghua Er Ke Za Zhi; 2008 Feb; 46(2):111-4. PubMed ID: 19099684
[TBL] [Abstract][Full Text] [Related]
10. Yeast-generated virus-like particles as antigens for detection of human bocavirus 1-4 specific antibodies in human serum.
Tamošiūnas PL; Petraitytė-Burneikienė R; Bulavaitė A; Marcinkevičiūtė K; Simutis K; Lasickienė R; Firantienė R; Ėmužytė R; Žvirblienė A; Sasnauskas K
Appl Microbiol Biotechnol; 2016 Jun; 100(11):4935-46. PubMed ID: 26846623
[TBL] [Abstract][Full Text] [Related]
11. Characterization of human bocavirus-like particles generated by recombinant baculoviruses.
Fang L; Wang Z; Song S; Kataoka M; Ke C; Suzuki T; Wakita T; Takeda N; Li TC
J Virol Methods; 2014 Oct; 207():38-44. PubMed ID: 24992668
[TBL] [Abstract][Full Text] [Related]
12. Seroepidemiology of human bocavirus in Hokkaido prefecture, Japan.
Endo R; Ishiguro N; Kikuta H; Teramoto S; Shirkoohi R; Ma X; Ebihara T; Ishiko H; Ariga T
J Clin Microbiol; 2007 Oct; 45(10):3218-23. PubMed ID: 17699639
[TBL] [Abstract][Full Text] [Related]
13. [The expression of the capsid protein VP2 from human bocavirus identified in Beijing and the formation of virus-like particles (VLPs) in insect cells].
Zhao LQ; Qian Y; Ding YX; Zhu RN; Deng J; Wang F; Sun Y; Li Y
Bing Du Xue Bao; 2009 Sep; 25(5):333-8. PubMed ID: 19954108
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of parvovirus B19 and human bocavirus DNA in the heart of patients with no evidence of dilated cardiomyopathy or myocarditis.
Kuethe F; Lindner J; Matschke K; Wenzel JJ; Norja P; Ploetze K; Schaal S; Kamvissi V; Bornstein SR; Schwanebeck U; Modrow S
Clin Infect Dis; 2009 Dec; 49(11):1660-6. PubMed ID: 19863443
[TBL] [Abstract][Full Text] [Related]
15. High prevalence of antibodies against polyomavirus WU, polyomavirus KI, and human bocavirus in German blood donors.
Neske F; Prifert C; Scheiner B; Ewald M; Schubert J; Opitz A; Weissbrich B
BMC Infect Dis; 2010 Jul; 10():215. PubMed ID: 20646318
[TBL] [Abstract][Full Text] [Related]
16. T helper cell-mediated interferon-gamma expression after human parvovirus B19 infection: persisting VP2-specific and transient VP1u-specific activity.
Franssila R; Auramo J; Modrow S; Möbs M; Oker-Blom C; Käpylä P; Söderlund-Venermo M; Hedman K
Clin Exp Immunol; 2005 Oct; 142(1):53-61. PubMed ID: 16178856
[TBL] [Abstract][Full Text] [Related]
17. Human bocavirus--a novel parvovirus to infect humans.
Lindner J; Modrow S
Intervirology; 2008; 51(2):116-22. PubMed ID: 18536522
[TBL] [Abstract][Full Text] [Related]
18. [Expression of recombinant VP2 gene in insect sf9 cells and screening of clinical specimens].
Teng LF; Lin F; Zheng MY; Zheng CH; Wu F; Zeng AP; Huang EP; Mo YH; Zheng MQ; Li XY; Hou JY
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2009 Dec; 23(6):427-9. PubMed ID: 20718346
[TBL] [Abstract][Full Text] [Related]
19. Human bocavirus infections are common in Beijing population indicated by sero-antibody prevalence analysis.
Zhao LQ; Qian Y; Zhu RN; Deng J; Wang F; Dong HJ; Sun Y; Li Y
Chin Med J (Engl); 2009 Jun; 122(11):1289-92. PubMed ID: 19567139
[TBL] [Abstract][Full Text] [Related]
20. T-helper cell-mediated interferon-gamma, interleukin-10 and proliferation responses to a candidate recombinant vaccine for human parvovirus B19.
Franssila R; Hedman K
Vaccine; 2004 Sep; 22(27-28):3809-15. PubMed ID: 15315862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
